Global Insulin Market Research Report 2023

Publisher Name :
Date: 07-Jan-2023
No. of pages: 91
Inquire Before Buying

Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.

Highlights

The global Insulin market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

The major players in China Insulin market include Novo Nordisk, Eli Lilly, etc. The top 2 players occupy about 60% shares of the whole market. Tianjin and Jiangsu are main markets, they occupy about 60% of the whole market. Regular Human Insulin is the main type, with a share over 60%. Long Acting and Intermediate Acting are the main applications, which holds a share about 70%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Insulin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin.

The Insulin market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Insulin market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Insulin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

By Company

- Novo Nordisk

- Eli Lilly

- Sanofi-Aventis

- Tonghua Dongbao

- Ganlee

- United Laboratory

- Jiangsu Wanbang

Segment by Type

- Animal Insulin

- Regular Human Insulin

- Insulin Analogue

Segment by Application

- Short Acting

- Intermediate Acting

- Long Acting

- Pre-Mix Insulin

Consumption by Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Insulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Insulin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

Global Insulin Market Research Report 2023

Table of Contents
1 Lip Balm Market Overview
1.1 Product Overview and Scope of Lip Balm
1.2 Lip Balm Segment by Type
1.2.1 Global Lip Balm Market Value Comparison by Type (2023-2029)
1.2.2 Solid Cream Lip Balm
1.2.3 Liquid Gel Lip Balm
1.3 Lip Balm Segment by Application
1.3.1 Global Lip Balm Market Value by Application: (2023-2029)
1.3.2 Lip Balm For Women
1.3.3 Lip Balm For Men
1.3.4 Lip Balm For Baby
1.3.5 Other Dedicated Lip Balm
1.4 Global Lip Balm Market Size Estimates and Forecasts
1.4.1 Global Lip Balm Revenue 2018-2029
1.4.2 Global Lip Balm Sales 2018-2029
1.4.3 Global Lip Balm Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Lip Balm Market Competition by Manufacturers
2.1 Global Lip Balm Sales Market Share by Manufacturers (2018-2023)
2.2 Global Lip Balm Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Lip Balm Average Price by Manufacturers (2018-2023)
2.4 Global Lip Balm Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Lip Balm, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Lip Balm, Product Type & Application
2.7 Lip Balm Market Competitive Situation and Trends
2.7.1 Lip Balm Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Lip Balm Players Market Share by Revenue
2.7.3 Global Lip Balm Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Lip Balm Retrospective Market Scenario by Region
3.1 Global Lip Balm Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Lip Balm Global Lip Balm Sales by Region: 2018-2029
3.2.1 Global Lip Balm Sales by Region: 2018-2023
3.2.2 Global Lip Balm Sales by Region: 2024-2029
3.3 Global Lip Balm Global Lip Balm Revenue by Region: 2018-2029
3.3.1 Global Lip Balm Revenue by Region: 2018-2023
3.3.2 Global Lip Balm Revenue by Region: 2024-2029
3.4 North America Lip Balm Market Facts & Figures by Country
3.4.1 North America Lip Balm Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Lip Balm Sales by Country (2018-2029)
3.4.3 North America Lip Balm Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Lip Balm Market Facts & Figures by Country
3.5.1 Europe Lip Balm Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Lip Balm Sales by Country (2018-2029)
3.5.3 Europe Lip Balm Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Lip Balm Market Facts & Figures by Country
3.6.1 Asia Pacific Lip Balm Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Lip Balm Sales by Country (2018-2029)
3.6.3 Asia Pacific Lip Balm Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Lip Balm Market Facts & Figures by Country
3.7.1 Latin America Lip Balm Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Lip Balm Sales by Country (2018-2029)
3.7.3 Latin America Lip Balm Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Lip Balm Market Facts & Figures by Country
3.8.1 Middle East and Africa Lip Balm Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Lip Balm Sales by Country (2018-2029)
3.8.3 Middle East and Africa Lip Balm Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Lip Balm Sales by Type (2018-2029)
4.1.1 Global Lip Balm Sales by Type (2018-2023)
4.1.2 Global Lip Balm Sales by Type (2024-2029)
4.1.3 Global Lip Balm Sales Market Share by Type (2018-2029)
4.2 Global Lip Balm Revenue by Type (2018-2029)
4.2.1 Global Lip Balm Revenue by Type (2018-2023)
4.2.2 Global Lip Balm Revenue by Type (2024-2029)
4.2.3 Global Lip Balm Revenue Market Share by Type (2018-2029)
4.3 Global Lip Balm Price by Type (2018-2029)
5 Segment by Application
5.1 Global Lip Balm Sales by Application (2018-2029)
5.1.1 Global Lip Balm Sales by Application (2018-2023)
5.1.2 Global Lip Balm Sales by Application (2024-2029)
5.1.3 Global Lip Balm Sales Market Share by Application (2018-2029)
5.2 Global Lip Balm Revenue by Application (2018-2029)
5.2.1 Global Lip Balm Revenue by Application (2018-2023)
5.2.2 Global Lip Balm Revenue by Application (2024-2029)
5.2.3 Global Lip Balm Revenue Market Share by Application (2018-2029)
5.3 Global Lip Balm Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Mentholatum
6.1.1 Mentholatum Corporation Information
6.1.2 Mentholatum Description and Business Overview
6.1.3 Mentholatum Lip Balm Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Mentholatum Lip Balm Product Portfolio
6.1.5 Mentholatum Recent Developments/Updates
6.2 Maybelline
6.2.1 Maybelline Corporation Information
6.2.2 Maybelline Description and Business Overview
6.2.3 Maybelline Lip Balm Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Maybelline Lip Balm Product Portfolio
6.2.5 Maybelline Recent Developments/Updates
6.3 Nivea
6.3.1 Nivea Corporation Information
6.3.2 Nivea Description and Business Overview
6.3.3 Nivea Lip Balm Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Nivea Lip Balm Product Portfolio
6.3.5 Nivea Recent Developments/Updates
6.4 Kiehl
6.4.1 Kiehl Corporation Information
6.4.2 Kiehl Description and Business Overview
6.4.3 Kiehl Lip Balm Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Kiehl Lip Balm Product Portfolio
6.4.5 Kiehl Recent Developments/Updates
6.5 MAC
6.5.1 MAC Corporation Information
6.5.2 MAC Description and Business Overview
6.5.3 MAC Lip Balm Sales, Revenue and Gross Margin (2018-2023)
6.5.4 MAC Lip Balm Product Portfolio
6.5.5 MAC Recent Developments/Updates
6.6 DHC
6.6.1 DHC Corporation Information
6.6.2 DHC Description and Business Overview
6.6.3 DHC Lip Balm Sales, Revenue and Gross Margin (2018-2023)
6.6.4 DHC Lip Balm Product Portfolio
6.6.5 DHC Recent Developments/Updates
6.7 SHISEIDO
6.6.1 SHISEIDO Corporation Information
6.6.2 SHISEIDO Description and Business Overview
6.6.3 SHISEIDO Lip Balm Sales, Revenue and Gross Margin (2018-2023)
6.4.4 SHISEIDO Lip Balm Product Portfolio
6.7.5 SHISEIDO Recent Developments/Updates
6.8 Lancome
6.8.1 Lancome Corporation Information
6.8.2 Lancome Description and Business Overview
6.8.3 Lancome Lip Balm Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Lancome Lip Balm Product Portfolio
6.8.5 Lancome Recent Developments/Updates
6.9 Neutrogena
6.9.1 Neutrogena Corporation Information
6.9.2 Neutrogena Description and Business Overview
6.9.3 Neutrogena Lip Balm Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Neutrogena Lip Balm Product Portfolio
6.9.5 Neutrogena Recent Developments/Updates
6.10 CHANEL
6.10.1 CHANEL Corporation Information
6.10.2 CHANEL Description and Business Overview
6.10.3 CHANEL Lip Balm Sales, Revenue and Gross Margin (2018-2023)
6.10.4 CHANEL Lip Balm Product Portfolio
6.10.5 CHANEL Recent Developments/Updates
6.11 Yue sai
6.11.1 Yue sai Corporation Information
6.11.2 Yue sai Lip Balm Description and Business Overview
6.11.3 Yue sai Lip Balm Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Yue sai Lip Balm Product Portfolio
6.11.5 Yue sai Recent Developments/Updates
6.12 Max Factor
6.12.1 Max Factor Corporation Information
6.12.2 Max Factor Lip Balm Description and Business Overview
6.12.3 Max Factor Lip Balm Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Max Factor Lip Balm Product Portfolio
6.12.5 Max Factor Recent Developments/Updates
6.13 Elizabeth Arden
6.13.1 Elizabeth Arden Corporation Information
6.13.2 Elizabeth Arden Lip Balm Description and Business Overview
6.13.3 Elizabeth Arden Lip Balm Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Elizabeth Arden Lip Balm Product Portfolio
6.13.5 Elizabeth Arden Recent Developments/Updates
6.14 Clinique
6.14.1 Clinique Corporation Information
6.14.2 Clinique Lip Balm Description and Business Overview
6.14.3 Clinique Lip Balm Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Clinique Lip Balm Product Portfolio
6.14.5 Clinique Recent Developments/Updates
6.15 MARY KAY
6.15.1 MARY KAY Corporation Information
6.15.2 MARY KAY Lip Balm Description and Business Overview
6.15.3 MARY KAY Lip Balm Sales, Revenue and Gross Margin (2018-2023)
6.15.4 MARY KAY Lip Balm Product Portfolio
6.15.5 MARY KAY Recent Developments/Updates
6.16 L'Oreal
6.16.1 L'Oreal Corporation Information
6.16.2 L'Oreal Lip Balm Description and Business Overview
6.16.3 L'Oreal Lip Balm Sales, Revenue and Gross Margin (2018-2023)
6.16.4 L'Oreal Lip Balm Product Portfolio
6.16.5 L'Oreal Recent Developments/Updates
6.17 NUXE
6.17.1 NUXE Corporation Information
6.17.2 NUXE Lip Balm Description and Business Overview
6.17.3 NUXE Lip Balm Sales, Revenue and Gross Margin (2018-2023)
6.17.4 NUXE Lip Balm Product Portfolio
6.17.5 NUXE Recent Developments/Updates
6.18 Revlon
6.18.1 Revlon Corporation Information
6.18.2 Revlon Lip Balm Description and Business Overview
6.18.3 Revlon Lip Balm Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Revlon Lip Balm Product Portfolio
6.18.5 Revlon Recent Developments/Updates
6.19 Burt's Bees
6.19.1 Burt's Bees Corporation Information
6.19.2 Burt's Bees Lip Balm Description and Business Overview
6.19.3 Burt's Bees Lip Balm Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Burt's Bees Lip Balm Product Portfolio
6.19.5 Burt's Bees Recent Developments/Updates
6.20 Blistex
6.20.1 Blistex Corporation Information
6.20.2 Blistex Lip Balm Description and Business Overview
6.20.3 Blistex Lip Balm Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Blistex Lip Balm Product Portfolio
6.20.5 Blistex Recent Developments/Updates
6.21 Vaseline
6.21.1 Vaseline Corporation Information
6.21.2 Vaseline Lip Balm Description and Business Overview
6.21.3 Vaseline Lip Balm Sales, Revenue and Gross Margin (2018-2023)
6.21.4 Vaseline Lip Balm Product Portfolio
6.21.5 Vaseline Recent Developments/Updates
6.22 EOS
6.22.1 EOS Corporation Information
6.22.2 EOS Lip Balm Description and Business Overview
6.22.3 EOS Lip Balm Sales, Revenue and Gross Margin (2018-2023)
6.22.4 EOS Lip Balm Product Portfolio
6.22.5 EOS Recent Developments/Updates
6.23 Carmex
6.23.1 Carmex Corporation Information
6.23.2 Carmex Lip Balm Description and Business Overview
6.23.3 Carmex Lip Balm Sales, Revenue and Gross Margin (2018-2023)
6.23.4 Carmex Lip Balm Product Portfolio
6.23.5 Carmex Recent Developments/Updates
6.24 Labello
6.24.1 Labello Corporation Information
6.24.2 Labello Lip Balm Description and Business Overview
6.24.3 Labello Lip Balm Sales, Revenue and Gross Margin (2018-2023)
6.24.4 Labello Lip Balm Product Portfolio
6.24.5 Labello Recent Developments/Updates
6.25 ChapStick
6.25.1 ChapStick Corporation Information
6.25.2 ChapStick Lip Balm Description and Business Overview
6.25.3 ChapStick Lip Balm Sales, Revenue and Gross Margin (2018-2023)
6.25.4 ChapStick Lip Balm Product Portfolio
6.25.5 ChapStick Recent Developments/Updates
6.26 Lip Smacker
6.26.1 Lip Smacker Corporation Information
6.26.2 Lip Smacker Lip Balm Description and Business Overview
6.26.3 Lip Smacker Lip Balm Sales, Revenue and Gross Margin (2018-2023)
6.26.4 Lip Smacker Lip Balm Product Portfolio
6.26.5 Lip Smacker Recent Developments/Updates
6.27 AVON
6.27.1 AVON Corporation Information
6.27.2 AVON Lip Balm Description and Business Overview
6.27.3 AVON Lip Balm Sales, Revenue and Gross Margin (2018-2023)
6.27.4 AVON Lip Balm Product Portfolio
6.27.5 AVON Recent Developments/Updates
6.28 Lypsyl
6.28.1 Lypsyl Corporation Information
6.28.2 Lypsyl Lip Balm Description and Business Overview
6.28.3 Lypsyl Lip Balm Sales, Revenue and Gross Margin (2018-2023)
6.28.4 Lypsyl Lip Balm Product Portfolio
6.28.5 Lypsyl Recent Developments/Updates
6.29 CARSLAN
6.29.1 CARSLAN Corporation Information
6.29.2 CARSLAN Lip Balm Description and Business Overview
6.29.3 CARSLAN Lip Balm Sales, Revenue and Gross Margin (2018-2023)
6.29.4 CARSLAN Lip Balm Product Portfolio
6.29.5 CARSLAN Recent Developments/Updates
6.30 Ainuo
6.30.1 Ainuo Corporation Information
6.30.2 Ainuo Lip Balm Description and Business Overview
6.30.3 Ainuo Lip Balm Sales, Revenue and Gross Margin (2018-2023)
6.30.4 Ainuo Lip Balm Product Portfolio
6.30.5 Ainuo Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Lip Balm Industry Chain Analysis
7.2 Lip Balm Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Lip Balm Production Mode & Process
7.4 Lip Balm Sales and Marketing
7.4.1 Lip Balm Sales Channels
7.4.2 Lip Balm Distributors
7.5 Lip Balm Customers
8 Lip Balm Market Dynamics
8.1 Lip Balm Industry Trends
8.2 Lip Balm Market Drivers
8.3 Lip Balm Market Challenges
8.4 Lip Balm Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Insulin Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Insulin Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Insulin Market Competitive Situation by Manufacturers in 2022
Table 4. Global Insulin Sales (K MT) of Key Manufacturers (2018-2023)
Table 5. Global Insulin Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Insulin Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Insulin Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Insulin Average Price (USD/MT) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Insulin, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Insulin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Insulin, Product Type & Application
Table 12. Global Key Manufacturers of Insulin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Insulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Insulin Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Insulin Sales by Region (2018-2023) & (K MT)
Table 18. Global Insulin Sales Market Share by Region (2018-2023)
Table 19. Global Insulin Sales by Region (2024-2029) & (K MT)
Table 20. Global Insulin Sales Market Share by Region (2024-2029)
Table 21. Global Insulin Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Insulin Revenue Market Share by Region (2018-2023)
Table 23. Global Insulin Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Insulin Revenue Market Share by Region (2024-2029)
Table 25. North America Insulin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Insulin Sales by Country (2018-2023) & (K MT)
Table 27. North America Insulin Sales by Country (2024-2029) & (K MT)
Table 28. North America Insulin Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Insulin Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Insulin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Insulin Sales by Country (2018-2023) & (K MT)
Table 32. Europe Insulin Sales by Country (2024-2029) & (K MT)
Table 33. Europe Insulin Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Insulin Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Insulin Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Insulin Sales by Region (2018-2023) & (K MT)
Table 37. Asia Pacific Insulin Sales by Region (2024-2029) & (K MT)
Table 38. Asia Pacific Insulin Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Insulin Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Insulin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Insulin Sales by Country (2018-2023) & (K MT)
Table 42. Latin America Insulin Sales by Country (2024-2029) & (K MT)
Table 43. Latin America Insulin Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Insulin Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Insulin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Insulin Sales by Country (2018-2023) & (K MT)
Table 47. Middle East & Africa Insulin Sales by Country (2024-2029) & (K MT)
Table 48. Middle East & Africa Insulin Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Insulin Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Insulin Sales (K MT) by Type (2018-2023)
Table 51. Global Insulin Sales (K MT) by Type (2024-2029)
Table 52. Global Insulin Sales Market Share by Type (2018-2023)
Table 53. Global Insulin Sales Market Share by Type (2024-2029)
Table 54. Global Insulin Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Insulin Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Insulin Revenue Market Share by Type (2018-2023)
Table 57. Global Insulin Revenue Market Share by Type (2024-2029)
Table 58. Global Insulin Price (USD/MT) by Type (2018-2023)
Table 59. Global Insulin Price (USD/MT) by Type (2024-2029)
Table 60. Global Insulin Sales (K MT) by Application (2018-2023)
Table 61. Global Insulin Sales (K MT) by Application (2024-2029)
Table 62. Global Insulin Sales Market Share by Application (2018-2023)
Table 63. Global Insulin Sales Market Share by Application (2024-2029)
Table 64. Global Insulin Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Insulin Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Insulin Revenue Market Share by Application (2018-2023)
Table 67. Global Insulin Revenue Market Share by Application (2024-2029)
Table 68. Global Insulin Price (USD/MT) by Application (2018-2023)
Table 69. Global Insulin Price (USD/MT) by Application (2024-2029)
Table 70. Novo Nordisk Corporation Information
Table 71. Novo Nordisk Description and Business Overview
Table 72. Novo Nordisk Insulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 73. Novo Nordisk Insulin Product
Table 74. Novo Nordisk Recent Developments/Updates
Table 75. Eli Lilly Corporation Information
Table 76. Eli Lilly Description and Business Overview
Table 77. Eli Lilly Insulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 78. Eli Lilly Insulin Product
Table 79. Eli Lilly Recent Developments/Updates
Table 80. Sanofi-Aventis Corporation Information
Table 81. Sanofi-Aventis Description and Business Overview
Table 82. Sanofi-Aventis Insulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 83. Sanofi-Aventis Insulin Product
Table 84. Sanofi-Aventis Recent Developments/Updates
Table 85. Tonghua Dongbao Corporation Information
Table 86. Tonghua Dongbao Description and Business Overview
Table 87. Tonghua Dongbao Insulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 88. Tonghua Dongbao Insulin Product
Table 89. Tonghua Dongbao Recent Developments/Updates
Table 90. Ganlee Corporation Information
Table 91. Ganlee Description and Business Overview
Table 92. Ganlee Insulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 93. Ganlee Insulin Product
Table 94. Ganlee Recent Developments/Updates
Table 95. United Laboratory Corporation Information
Table 96. United Laboratory Description and Business Overview
Table 97. United Laboratory Insulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 98. United Laboratory Insulin Product
Table 99. United Laboratory Recent Developments/Updates
Table 100. Jiangsu Wanbang Corporation Information
Table 101. Jiangsu Wanbang Description and Business Overview
Table 102. Jiangsu Wanbang Insulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 103. Jiangsu Wanbang Insulin Product
Table 104. Jiangsu Wanbang Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Insulin Distributors List
Table 108. Insulin Customers List
Table 109. Insulin Market Trends
Table 110. Insulin Market Drivers
Table 111. Insulin Market Challenges
Table 112. Insulin Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Insulin
Figure 2. Global Insulin Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Insulin Market Share by Type in 2022 & 2029
Figure 4. Animal Insulin Product Picture
Figure 5. Regular Human Insulin Product Picture
Figure 6. Insulin Analogue Product Picture
Figure 7. Global Insulin Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Insulin Market Share by Application in 2022 & 2029
Figure 9. Short Acting
Figure 10. Intermediate Acting
Figure 11. Long Acting
Figure 12. Pre-Mix Insulin
Figure 13. Global Insulin Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Insulin Market Size (2018-2029) & (US$ Million)
Figure 15. Global Insulin Sales (2018-2029) & (K MT)
Figure 16. Global Insulin Average Price (USD/MT) & (2018-2029)
Figure 17. Insulin Report Years Considered
Figure 18. Insulin Sales Share by Manufacturers in 2022
Figure 19. Global Insulin Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Insulin Players: Market Share by Revenue in 2022
Figure 21. Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Insulin Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. North America Insulin Sales Market Share by Country (2018-2029)
Figure 24. North America Insulin Revenue Market Share by Country (2018-2029)
Figure 25. U.S. Insulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Insulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Insulin Sales Market Share by Country (2018-2029)
Figure 28. Europe Insulin Revenue Market Share by Country (2018-2029)
Figure 29. Germany Insulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Insulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. Insulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Insulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Insulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Insulin Sales Market Share by Region (2018-2029)
Figure 35. Asia Pacific Insulin Revenue Market Share by Region (2018-2029)
Figure 36. China Insulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Japan Insulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. South Korea Insulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. India Insulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Australia Insulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. China Taiwan Insulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Indonesia Insulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Thailand Insulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Malaysia Insulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Latin America Insulin Sales Market Share by Country (2018-2029)
Figure 46. Latin America Insulin Revenue Market Share by Country (2018-2029)
Figure 47. Mexico Insulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Brazil Insulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Argentina Insulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Insulin Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa Insulin Revenue Market Share by Country (2018-2029)
Figure 52. Turkey Insulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Insulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. UAE Insulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of Insulin by Type (2018-2029)
Figure 56. Global Revenue Market Share of Insulin by Type (2018-2029)
Figure 57. Global Insulin Price (USD/MT) by Type (2018-2029)
Figure 58. Global Sales Market Share of Insulin by Application (2018-2029)
Figure 59. Global Revenue Market Share of Insulin by Application (2018-2029)
Figure 60. Global Insulin Price (USD/MT) by Application (2018-2029)
Figure 61. Insulin Value Chain
Figure 62. Insulin Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
  • Global Repaglinide Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 21-Mar-2023        Price: US 3260 Onwards        Pages: 124
    The Repaglinide market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Repaglinide industry, and breaks down according to the type, application, and consumption area of Repaglinide. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies.......
  • Global Human Insulin Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 21-Mar-2023        Price: US 3260 Onwards        Pages: 128
    The Human Insulin market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Human Insulin industry, and breaks down according to the type, application, and consumption area of Human Insulin. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading comp......
  • Global Gliclazide Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 14-Mar-2023        Price: US 3260 Onwards        Pages: 102
    The Gliclazide market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Gliclazide industry, and breaks down according to the type, application, and consumption area of Gliclazide. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies.......
  • 2023-2031 Report on Global Liraglutide Market by Player, Region, Type, Application and Sales Channel
    Published: 13-Mar-2023        Price: US 2500 Onwards        Pages: 91
    This report studies the Liraglutide market, covering market size for segment by type (Pills, Liquid, etc.), by application (Hospitals, Retail Pharmacy, etc.), by sales channel (Direct Channel, Distribution Channel), by player (HEC Pharm, Bachem, Bharat Pharmaceuticals, Kingpep Biotechnology, Shenzhen JYMed Technology, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market......
  • 2023-2031 Report on Global Insulin Glargine Market by Player, Region, Type, Application and Sales Channel
    Published: 13-Mar-2023        Price: US 2500 Onwards        Pages: 86
    This report studies the Insulin Glargine market, covering market size for segment by type (Single Dose Vial, Pre-filled Syringe, etc.), by application (Treat Type 2 Diabetes, Treat Type 1 Diabetes, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Sanofi-Aventis, Ganlee, Biocon, ..., , etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Ins......
  • Global Glipizide Market Research Report 2023
    Published: 09-Mar-2023        Price: US 2900 Onwards        Pages: 98
    Glipizide (CAS 29094-61-9), C21H27N5O4S, the formula weight is 445.54, and its form is white cyrstal powder. Highlights The global Glipizide market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. Glipizide is a hypoglycemic drug for non-insulin-dependent (II) type diabe......
  • Global Gliquidone Market Research Report 2023
    Published: 09-Mar-2023        Price: US 2900 Onwards        Pages: 91
    Gliquidone (CAS 33342-05-1), C27H33N3O6S, the formula weight is 527.63, and its form is white powder. Highlights The global Gliquidone market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. Glycollinone is a second-generation oral sulfonylurea hypoglycemic agent. It is ......
  • Global Diabetes Drugs Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 02-Mar-2023        Price: US 3260 Onwards        Pages: 98
    The Diabetes Drugs market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Diabetes Drugs industry, and breaks down according to the type, application, and consumption area of Diabetes Drugs. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading c......
  • Global Glimepiride Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 28-Feb-2023        Price: US 3260 Onwards        Pages: 115
    The Glimepiride market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Glimepiride industry, and breaks down according to the type, application, and consumption area of Glimepiride. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies.......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs